The Incidence of Thoracic Disc Herniation in Patients Presenting With Chronic Upper Back Pain

Kocaeli University

Status: Completed

Conditions: Thoracic Disc Herniation

Treatments: Drug: Diclofenac Sodium

Study type: Observational

Funder types: Other

Identifiers

NCT05313997

2022-20

Details and patient eligibility

About

Patients who applied to the Private Medar Hospital between February 2016 and February 2021 with chronic upper back pain and were diagnosed with Thoaracic Disc Herniatin (TDH) (with Thoracic vertebral MRI) and followed up for at least 1 year will be included in the study.

Patients diagnosed with TDH were included in the medical treatment and/or physical therapy program.

Before and after these treatment programs, the pain intensity of the patients was recorded with the visual analog scale (VAS).

The number of patients who applied to the Physical Medicine and Rehabilitation outpatient clinic with chronic upper back pain between February 2016 and February 2021 will be researched, and the demographic characteristics of those diagnosed with TDH will be selected and recorded in their files, their pre- and post-treatment VAS scores, and the results will be analyzed statistically.

Enrollment: 194 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• 18-65 years old
• admitted to the Private Medar Hospital Gölcük hospital between February 2016 and February 2021 with chronic upper back pain.
• Diagnosed with TDH as a result of thoracic vertebral MRI

Exclusion Criteria:Patients with

• vertebral fracture,
• developmental spinal deformity,
• spinal infection or tumor,
• chronic widespread pain syndrome such as fibromyalgia,
• diabetes mellitus,
• polyneuropathy
• rheumatological disease
• under 18 years old
• over 65 years old
• who have had previous back and neck surgery